| __timestamp | HUTCHMED (China) Limited | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 33472000 | 382096000000 |
| Thursday, January 1, 2015 | 47368000 | 345927000000 |
| Friday, January 1, 2016 | 66871000 | 312303000000 |
| Sunday, January 1, 2017 | 50675000 | 325441000000 |
| Monday, January 1, 2018 | 78821000 | 368298000000 |
| Tuesday, January 1, 2019 | 91944000 | 492381000000 |
| Wednesday, January 1, 2020 | 111234000 | 455833000000 |
| Friday, January 1, 2021 | 207447000 | 526087000000 |
| Saturday, January 1, 2022 | 267587000 | 633325000000 |
| Sunday, January 1, 2023 | 303055000 | 729924000000 |
| Monday, January 1, 2024 | 729924000000 |
Unlocking the unknown
In the competitive world of pharmaceuticals, innovation is key. Takeda Pharmaceutical Company Limited and HUTCHMED (China) Limited are two giants in this arena, each with a distinct approach to research and development (R&D) investment. Over the past decade, Takeda has consistently outpaced HUTCHMED, investing nearly 3,000% more in R&D annually. In 2023, Takeda's R&D expenses reached a staggering $730 billion, while HUTCHMED's were approximately $303 million. This trend highlights Takeda's commitment to innovation, with a steady increase in R&D spending since 2014. Meanwhile, HUTCHMED has shown significant growth, with a nearly 900% increase in R&D expenses over the same period. As we look to the future, the question remains: will HUTCHMED close the gap, or will Takeda continue to lead the charge in pharmaceutical innovation?
Who Prioritizes Innovation? R&D Spending Compared for Novo Nordisk A/S and Takeda Pharmaceutical Company Limited
Analyzing R&D Budgets: Merck & Co., Inc. vs HUTCHMED (China) Limited
Research and Development Investment: Amgen Inc. vs Takeda Pharmaceutical Company Limited
Zoetis Inc. vs HUTCHMED (China) Limited: Strategic Focus on R&D Spending
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs Bio-Techne Corporation
Takeda Pharmaceutical Company Limited or Verona Pharma plc: Who Invests More in Innovation?
R&D Spending Showdown: Takeda Pharmaceutical Company Limited vs Ionis Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Takeda Pharmaceutical Company Limited or HUTCHMED (China) Limited
Comparing Innovation Spending: Intra-Cellular Therapies, Inc. and HUTCHMED (China) Limited
Comparing Innovation Spending: Alpine Immune Sciences, Inc. and HUTCHMED (China) Limited
Research and Development Investment: HUTCHMED (China) Limited vs Wave Life Sciences Ltd.
R&D Spending Showdown: HUTCHMED (China) Limited vs Evotec SE